3/26
08:12 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $16.00. They now have a "buy" rating on the stock.
3/25
04:08 pm
nktx
Nkarta: NK Cell Therapy Advancement On Two Fronts [Seeking Alpha]
Medium
Report
Nkarta: NK Cell Therapy Advancement On Two Fronts [Seeking Alpha]
3/25
10:06 am
nktx
Nkarta, Nuvation Bio, Canopy Growth among healthcare movers Mar. 25, 2024 10:00 AM ET By: Tiyashi Datta , SA News Editor [Seeking Alpha]
Medium
Report
Nkarta, Nuvation Bio, Canopy Growth among healthcare movers Mar. 25, 2024 10:00 AM ET By: Tiyashi Datta , SA News Editor [Seeking Alpha]
3/25
06:36 am
nktx
Nkarta Announces Pricing of $240 Million Underwritten Offering [Yahoo! Finance]
Low
Report
Nkarta Announces Pricing of $240 Million Underwritten Offering [Yahoo! Finance]
3/25
06:30 am
nktx
Nkarta Announces Pricing of $240 Million Underwritten Offering
Medium
Report
Nkarta Announces Pricing of $240 Million Underwritten Offering
3/22
11:20 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at Mizuho from $31.00 to $25.00. They now have a "buy" rating on the stock.
High
Report
Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at Mizuho from $31.00 to $25.00. They now have a "buy" rating on the stock.
3/22
10:03 am
nktx
Canopy Growth, Capricor Therapeutics, GT Biopharma among healthcare movers [Seeking Alpha]
High
Report
Canopy Growth, Capricor Therapeutics, GT Biopharma among healthcare movers [Seeking Alpha]
3/22
08:07 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $16.00 price target on the stock, up previously from $13.00.
High
Report
Nkarta, Inc. (NASDAQ: NKTX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $16.00 price target on the stock, up previously from $13.00.
3/22
08:07 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at HC Wainwright from $22.00 to $20.00. They now have a "buy" rating on the stock.
High
Report
Nkarta, Inc. (NASDAQ: NKTX) had its price target lowered by analysts at HC Wainwright from $22.00 to $20.00. They now have a "buy" rating on the stock.
3/22
08:07 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
High
Report
Nkarta, Inc. (NASDAQ: NKTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
3/21
04:47 pm
nktx
Nkarta GAAP EPS of -$0.57 beats by $0.03 [Seeking Alpha]
High
Report
Nkarta GAAP EPS of -$0.57 beats by $0.03 [Seeking Alpha]
3/21
04:14 pm
nktx
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
High
Report
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
3/21
04:01 pm
nktx
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
High
Report
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
3/13
01:34 pm
nktx
Nkarta's Strategic Advances In Cell Therapy For Autoimmune Disorders [Seeking Alpha]
Low
Report
Nkarta's Strategic Advances In Cell Therapy For Autoimmune Disorders [Seeking Alpha]
3/5
09:11 am
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at Mizuho from $9.00 to $31.00. They now have a "buy" rating on the stock.
Low
Report
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at Mizuho from $9.00 to $31.00. They now have a "buy" rating on the stock.
2/28
08:01 am
nktx
Nkarta to Participate in Upcoming Investor Conferences
Medium
Report
Nkarta to Participate in Upcoming Investor Conferences
1/19
01:41 pm
nktx
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Nkarta Inc. (NASDAQ: NKTX)
Low
Report
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Nkarta Inc. (NASDAQ: NKTX)
1/16
04:18 pm
nktx
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at HC Wainwright from $10.00 to $22.00. They now have a "buy" rating on the stock.
Medium
Report
Nkarta, Inc. (NASDAQ: NKTX) had its price target raised by analysts at HC Wainwright from $10.00 to $22.00. They now have a "buy" rating on the stock.
1/16
05:32 am
nktx
Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains [Yahoo! Finance]
Low
Report
Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains [Yahoo! Finance]